Lung cancer

There are 1,431 papers on lung cancer in aging research: 74 trials and 780 observational studies in people, 67 in animals, 21 in cells, 309 reviews. The newest story, Nov 17, 2026: “Four blood fats linked to lung disease and lung cancer deaths”.

Disease

1,431 papers study it564 more mention it499 findings

159 new papers in 30 daysSee all 1,995 papers on lung cancer

At a glance

Lung cancer risk is linked with accelerated biological aging and clonal hematopoiesis of indeterminate potential in human cohorts, including GrimAge and DunedinPACE associations adjusted for age and smoking. Longer telomeres are also linked with higher risk. Observational studies associate smoking and particulate air pollution with higher risk, while a human trial reports lower lung cancer incidence with Centrum Silver.

499 findings in 332 papers from 1985 to 2026, 118 of them since April 2026

“with significantly higher incidence in the LDCT + group (21.8 % vs 3.0 %, p < 0.0001)”
Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trialLung cancer (Amsterdam, Netherlands)2026doi:10.1016/j.lungcan.2026.109629
  • Human trial74
  • Humans780
  • Animals67
  • Cells21
  • In silico167

Interventions

21

Lung cancer screening

upin humans1downin humans1

1 study
  1. Lung cancer screening is linked with higher lung cancer in humans (early-stage incidence) (APC, 4.9%).

    “Early-stage incidence increased (APC, 4.9%; 95% confidence interval (CI), -1.6-1.8%)”

    Humansearly-stage incidencelung2014-2023n = 1,006

    Incidence and mortality trends after introduction of lung cancer screening in a community-based healthcare system

    Cancer epidemiology

  2. Lung cancer screening is linked with lower lung cancer in humans (late-stage incidence) (APC, -5.2%; 95% CI, -9.8% to -0.3%).

    “late-stage incidence decreased (APC, -5.2%; 95% CI, -9.8% to -0.3%)”

    Humanslate-stage incidencelung2014-2023n = 1,006

    Incidence and mortality trends after introduction of lung cancer screening in a community-based healthcare system

    Cancer epidemiology

More on Lung cancer screening

Multivitamin

downin humans1HR 0.62

1 study
  1. Multivitamin protects against lung cancer in humans (HR: 0.62; 95% CI: 0.42, 0.92).

    “However, a daily MVM significantly reduced lung cancer compared with placebo (HR: 0.62; 95% CI: 0.42, 0.92).”

    Human trialCentrum Silvermedian (IQR) 3.6 (3.2–4.2) yn = 21,442

    Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial

    The American journal of clinical nutrition

  2. Multivitamin protects against lung cancer in humans (HR 0.62, 95% CI 0.42–0.92).

    “We observed a protective effect of a daily MVM on lung cancer (HR: 0.62; 95% CI: 0.42, 0.92).”

    Human trialmultivitamin-multimineral supplement3.6 yn = 21,442

    Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial

    The American journal of clinical nutrition

More on Multivitamin

AREDS2 supplementation

no changein humans1

1 study
  1. AREDS2 supplementation showed no clear effect on lung cancer in smokers.

    “without increasing the risk of lung cancer in smokers”

    Reviewin smokers

    AREDS2 as a Retinal Protective Strategy Against Aging: A Literature Review from a Geroscience Perspective

    Cermin Dunia Kedokteran

More on AREDS2 supplementation

Chest radiography

no changein humans1OR 0.5

1 study
  1. Chest radiography showed no clear effect on lung cancer in individuals who smoke (OR = 0.50, 95% CI 0.09-2.74).

    “Chest radiography demonstrated a lower but statistically nonsignificant rate of lung cancer detection compared with controls (odds ratio OR = 0.50; 95% confidence intervals: 0.09-2.74).”

    Reviewin individuals who smoke

    Efficacy of Chest Radiograph in Comparison to no Intervention in Screening for Lung Cancer in People who Smoke: A Systematic Review

    Annals of African medicine

More on Chest radiography

Low-carbohydrate diet score

no changein humans1HR 1.09

1 study
  1. Low-carbohydrate diet score was not clearly linked with lung cancer in humans (fully adjusted model, Q4 vs Q1) (HR 1.09, 95% CI 0.95–1.25).

    “LCD was not significantly associated with lung cancer risk after multivariable adjustment”

    Humansfully adjusted model, Q4 vs Q1

    Higher carbohydrate quality, but not quantity, is associated with lower lung cancer risk in a population-based prospective cohort study

    Frontiers in nutrition

More on Low-carbohydrate diet score

Smoking

mediatesin humans1

1 study
  1. Smoking is linked with lung cancer in humans (mediating childhood adversity and lung cancer risk) (approximately 40%).

    “Smoking severity was higher among participants with childhood adversity and accounted for approximately 40% of the observed association”

    Humansmediating childhood adversity and lung cancer riskn = 156,798

    Impact of Adverse Childhood Experience on Lung Cancer Risk: A Population-Based Prospective Cohort Study

    Cancer control : journal of the Moffitt Cancer Center

More on Smoking

Total body irradiation

no changein humans1

1 study
  1. Total body irradiation was not clearly linked with lung cancer in the absence of smoking vs no TBI never smokers (asHR 0.6, 95% CI 0.2-1.7).

    “TBI exposure in the absence of smoking did not increase the risk (asHR, 0.6; 95% CI, 0.2-1.7).”

    Humansin the absence of smoking vs no TBI never smokersn = 3,767

    Total body irradiation and smoking interact to increase lung cancer risk after blood or marrow transplantation

    Blood advances

More on Total body irradiation

Nutrient-rich food score

no changein humans1OR 0.46

1 study
  1. Nutrient-rich food score was not clearly linked with lung cancer in humans (OR = 0.46, 95% CI: 0.16-1.32).

    “while this relationship failed to reach significant level for women (OR = 0.46, 95% CI: 0.16-1.32)”

    Humansfemales

    The association between Nutrient-Rich food score (NRFS) and the odds of lung cancer risk: a case-control study in Iran

    BMC nutrition

More on Nutrient-rich food score

Reprogrammed CD8-positive t cells

downin mice1

1 study
  1. Reprogrammed CD8-positive t cells decrease lung cancer in mice (orthotopic Lewis lung carcinoma model).

    “The antitumor effect of rCD8+ T cells in aged mice was found to be inferior to that in young mice”

    Animalsorthotopic Lewis lung carcinoma modelmales

    Age-related features of lung cancer treatment using reprogrammed CD8 positive T cells in mice subjected to injection of Lewis lung carcinoma cells

    Thoracic cancer

More on Reprogrammed CD8-positive t cells

Glucosamine

no changein humans1HR 0.99

1 study
  1. Glucosamine was not clearly linked with lung cancer in patients with osteoarthritis (HR 0.99, 95% CI 0.83–1.18).

    “For lung cancer, the HR with glucosamine treatment was 0.99 (95% CI 0.83-1.18)”

    Humansin patients with osteoarthritis

    Glucosamine and Cancer Incidence in Osteoarthritis: A Prevalent New-User Cohort Design

    Arthritis care & research

More on Glucosamine

Lutein + zeaxanthin

no changein humans1OR 1.15

1 study
  1. Lutein + zeaxanthin showed no clear effect on lung cancer in humans (10-year follow-up) (OR 1.15 (95% CI, 0.79-1.66)).

    “and 1.15 (95% CI, 0.79-1.66; P = .46) for lutein/zeaxanthin.”

    Human trial10-year follow-up10 yearsn = 3,882

    Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

    JAMA ophthalmology

More on Lutein + zeaxanthin

All 21

Effects

13

Mortality

downin humans1upin humans1−4.7% per year

2 studies
  1. Lung cancer is linked with lower mortality in humans (-4.7% per year).

    “lung cancer death rates decreased 4.7% per year among males and 3.0% among females.”

    Humansmales

    Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer

    Cancer

  2. Lung cancer is linked with higher mortality in environmental asbestos-exposed districts (2.68-fold).

    “LC mortality exceeded mesothelioma mortality 2.68-fold and accounted for greater YLL”

    Humansin environmental asbestos-exposed districts

    Environmental asbestos exposure and lung cancer burden compared with mesothelioma in rural Türkiye: A 33-Year population-based cohort study

    Lung cancer (Amsterdam, Netherlands)

Survival

upin humans1

1 study
  1. Lung cancer is linked with better survival in humans (lung cancer) (doubled).

    “5-year relative survival for lung cancer doubled.”

    Humanslung cancer

    Annual Report to the Nation on the Status of Cancer, featuring 21st century progress against lung cancer

    Cancer

MAX

downin human cells1

1 study
  1. Lung cancer decreases MAX in tumor tissue vs tumor-free tissue (p < 0.01).

    “Correspondingly, TT showed down-regulation of gene expression (p < 0.01) with strong inverse associations to hypermethylation; CAV1 was the exception, demonstrating up-regulation with hypomethylation in NSCLC TT.”

    Cellsin tumor tissue vs tumor-free tissuelung

    A Precision Epigenetic Approach to Non-Invasive Lung Cancer Screening Using Gene- Specific cfDNA Methylation

    Research SquarePreprint

More on MAX

DNA methylation

upin human cells1

1 study
  1. Lung cancer increases DNA methylation in tumor tissue vs tumor-free tissue (68.45%, 56.94%, and 75.97% vs 20.42%, 15.28%, and 29.57% (p < 0.05 to p < 0.001)).

    “In TT, methylation frequencies for MAX, MTURN and HLA-B were significantly elevated 68.45%, 56.94%, and 75.97%—compared with TF (20.42%, 15.28%, and 29.57%; p < 0.05 to p < 0.001).”

    Cellsin tumor tissue vs tumor-free tissuelung

    A Precision Epigenetic Approach to Non-Invasive Lung Cancer Screening Using Gene- Specific cfDNA Methylation

    Research SquarePreprint

More on DNA methylation

MIR323B

downin silico1

1 study
  1. Lung cancer decreases MIR323B in silico (lung cancer).

    “24, including hsa-mir-196a and hsa-mir-323b found to be downregulated”

    In silicolung cancerlung

    Analysis of Age-Specific Dysregulation of miRNAs in Lung Cancer Via Machine learning: Biomarker Identification and Therapeutic Implications in Patients Aged 60 and Above

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on MIR323B

MIR196A1

downin silico1

1 study
  1. Lung cancer decreases MIR196A1 in silico (lung cancer).

    “24, including hsa-mir-196a and hsa-mir-323b found to be downregulated”

    In silicolung cancerlung

    Analysis of Age-Specific Dysregulation of miRNAs in Lung Cancer Via Machine learning: Biomarker Identification and Therapeutic Implications in Patients Aged 60 and Above

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on MIR196A1

HSA-MIR-1911

upin silico1

1 study
  1. Lung cancer increases HSA-MIR-1911 in silico (lung cancer).

    “Filtering for significance identified that 25 miRNAs, with hsa-mir-1911 upregulated”

    In silicolung cancerlung

    Analysis of Age-Specific Dysregulation of miRNAs in Lung Cancer Via Machine learning: Biomarker Identification and Therapeutic Implications in Patients Aged 60 and Above

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

More on HSA-MIR-1911

Terpenoids

upin humans1

1 study
  1. Lung cancer is linked with higher terpenoids in lung cancer patients vs healthy controls.

    “LC patients exhibited markedly increased levels of terpenoids and aldehydes, consistent with heightened oxidative stress, including lipid peroxidation, and perturbed metabolic pathways”

    Humansin lung cancer patients vs healthy controlsurine

    Urinary Volatilomic Signatures for Non-Invasive Detection of Lung Cancer: A HS-SPME/GC-MS Proof-of-Concept Study

    International journal of molecular sciences

More on Terpenoids

Rectus femoris cross-sectional area

downin humans1

1 study
  1. Lung cancer is linked with lower rectus femoris cross-sectional area in humans (compared to benign controls).

    “Lung cancer patients exhibited lower RFthick, RFcsa, and CSmean but higher RFmgv compared to benign controls, with significant differences in RFcsa, RFmgv, and CSmean among the groups (P < .05).”

    Humanscompared to benign controls

    Ultrasonography of the rectus femoris, a tool to assess the severity of sarcopenia in lung cancer patients: An observational study

    Medicine

More on Rectus femoris cross-sectional area

Non-cancer mortality

upin humans1

1 study
  1. Lung cancer is linked with higher non-cancer mortality in humans (beyond 5 years post-diagnosis) (SMR 2.24 (95% CI 2.22-2.26)).

    “Non-cancer-related deaths rose significantly over time, increasing from 7.72% within 1 year to 53.97% beyond 5 years post-diagnosis (overall SMR = 2.24, 95% CI 2.22-2.26)”

    Humansbeyond 5 years post-diagnosis

    Non-Cancer-Related Causes' Impact on Lung Cancer Survival: SEER Analysis

    Indian journal of surgical oncology

All 13

Upstream

22

GLP1R

no changein humans1

1 study
  1. GLP1R was not clearly linked with lung cancer in humans (genetically proxied GLP1R expression tested using drug-target cis-Mendelian randomization).

    “MR showed no association between GLP1R expression and lung cancer”

    Humansgenetically proxied GLP1R expression tested using drug-target cis-Mendelian randomization

    Glucagon-like peptide-1 receptor agonists and lung cancer risk in patients with type 2 diabetes and pulmonary nodules

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

More on GLP1R

Lung adenocarcinoma

upin humans1

1 study
  1. Lung adenocarcinoma is linked with higher lung cancer in humans (temporal trend 2001 to 2020) (AAPC=35.1, 95% CI 14.2-50.2).

    “Joinpoint regression analysis demonstrated a consistent long-term increase in adenocarcinoma (AAPC=35.1, 95% CI 14.2-50.2)”

    Humanstemporal trend 2001 to 2020lung2001 to 2020

    Temporal Trends in Lung Cancer and Histological Subtype Incidence and Bayesian Projections to 2030 in China: Population-Based Quantitative Study

    JMIR public health and surveillance

More on Lung adenocarcinoma

14-protein plasma signature

no changein humans1

1 study
  1. 14-protein plasma signature was not clearly linked with lung cancer in humans.

    “two-sample Mendelian randomisation provides no evidence that any of the 14 proteins causally influence lung cancer”

    Humans

    The 14-protein lung cancer signature: questions of prediction, specificity, and causality

    medRxivPreprint

More on 14-protein plasma signature

Gamma-glutamylglutamine

mediatesin humans1

1 study
  1. Gamma-glutamylglutamine is linked with lung cancer in humans (for particulate matter and ozone).

    “Four metabolites, including γ-glutamylglutamine, phenylacetylglutamate, N-(2-furoyl)glycine, and 4-vinylguaiacol glucuronide, significantly mediate associations for particulate matter and ozone”

    Humansfor particulate matter and ozonen = 1,357

    Blood metabolomic signatures linking air pollution to lung cancer in the Cancer Prevention Studies

    Nature communications

More on Gamma-glutamylglutamine

Metabolic syndrome

no changein humans1HR 1.03

1 study
  1. Metabolic syndrome was not clearly linked with lung cancer in never-smoking women (HR: 1.03, 95% CI 0.99-1.07).

    “but not in women (HR: 1.03, 95% CI 0.99-1.07)”

    Humansin never-smoking womenfemales

    Impact of Metabolic Syndrome on Risk of Lung Cancer among Korean Never-Smokers: A Nationwide Population-Based Cohort Study

    Cancer research and treatment

More on Metabolic syndrome

FOXO3GENOTYPE

no changein humans1

1 study
  1. FOXO3GENOTYPE was not clearly linked with lung cancer in humans (current smokers).

    “In contrast, no genotype-related differences were observed among current smokers.”

    Humanscurrent smokersmales

    Gene variant linked to lower lung cancer risk in former smokers

    Translational lung cancer research

More on FOXO3GENOTYPE

Risk transfer pathway

downin silico1−68%

1 study
  1. risk transfer pathway decreases lung cancer in silico (simulated intervention via deep Q-network in high-risk group) (-68.2%).

    “Lung cancer incidence in the high risk group had declined by 68.2% through risk transfer of model-based simulation”

    In silicosimulated intervention via deep Q-network in high-risk grouplung

    Research on Risk Transfer Pathways for Lung Cancer Among Middle-Aged and Older Individuals Using Deep Reinforcement Learning: Retrospective Cohort Study

    JMIR medical informatics

Genetically proxied BMI

no changein humans1OR 1.05

1 study
  1. Genetically proxied BMI showed no clear effect on lung cancer in humans (OR: 1.05; 95% CI 0.99-1.12).

    “genetically proxied BMI was associated with a non-significant increased risk of lung cancer (OR: 1.05; 95% CI 0.99-1.12)”

    Reviewgenetically proxied

    Body mass index (BMI) and risk of lung cancer: a systematic review and meta-analysis of studies using directly measured and genetically proxied measures of BMI

    Cancer causes & control : CCC

More on Genetically proxied BMI

Creatinine

no changein humans1

1 study
  1. Creatinine was not clearly linked with lung cancer in humans.

    “No significant association was observed in women.”

    Humansfemales

    Sex-specific associations of creatinine and antioxidant biomarkers with lung cancer risk by drinking and smoking behavior: A prospective cohort study

    Cancer epidemiology

More on Creatinine

EML4-ALK

upin mice1

1 study
  1. EML4-ALK induces lung cancer in mice (single driver fusion).

    “mice develop lung cancer from a single Eml4-Alk driver fusion”

    Reviewsingle driver fusionlung

    Testing Nature's Defenses: Inducing Cancer in the Naked Mole Rat

    Cancer discovery

More on EML4-ALK

All 22

Associations

341

Smoking

upin humans15mixedin humans1+110% dalysHR 1.82–5.94

16 studies
  1. Smoking is associated with lung cancer in humans (lung transplant recipients) (HR 1.82).

    “donor smoking history (HR 1.82), ILD/pulmonary fibrosis (HR 1.49), older recipient age (HR 1.37 per 10 years), and cumulative recipient smoking exposure (HR 1.13 per 10 pack-years) were associated with LC development.”

    Humanslung transplant recipientsdonor smoking historylung

    De Novo Lung Cancer after Lung Transplantation: Rethinking Surveillance and Early Detection

    Clinical lung cancer

  2. Smoking is linked with a higher risk of lung cancer in humans (ever smoking in Alaskan/Native American men) (AF 92.0% (0.91-0.92)).

    “The AF for lung cancer ranged from 65.0% (0.64-0.67) in Asian/Pacific Islander women to 92.0% (0.91-0.92) in Alaskan/Native American men.”

    Humansever smoking in Alaskan/Native American menmales

    Cancer attributable to cigarette smoking by ethnic group in the US in 2022-2023

    Cancer epidemiology

  3. Smoking is associated with lung cancer in humans with disease status.

    “Age and smoking status were significantly associated with disease status”

    Humanswith disease statusn = 118

    Explainable AI-based breath metabolite profiling for early lung cancer detection

    Biosensors & bioelectronics

  4. Smoking is associated with lung cancer in China, 1990-2023 (+109.97% DALYs).

    “China experienced a continuous increase in the burden attributable to smoking (DALYs increased by 109.97%)”

    Humansin China, 1990-2023

    Trends in lung cancer burden, risk factors, and disease projections in China and the United States, 1990-2023

    Chinese medical journal pulmonary and critical care medicine

  5. Smoking is linked with a higher risk of lung cancer in humans (current cigarette smokers) (8.85% versus 5.74%).

    “The 5-year cumulative lung cancer incidence in people who currently smoked both types of tobacco products was 8.85%, versus 5.74% for cigarette only current smokers.”

    Humanscurrent cigarette smokers5-yearn = 511

    The effect of cigar, cigarillo and pipe smoking on lung cancer risk and screening eligibility

    British journal of cancer

  6. Smoking is linked with a higher risk of lung cancer in humans (Attribution score: 10/10).

    “Smoking remained the predominant risk factor (Attribution score: 10/10)”

    Humans

    Diverging Trajectories of Lung Cancer Burden in China, Japan, and South Korea: A Comparative Risk Assessment from the Global Burden of Disease Study 1990-2021

    Thoracic cancer

  7. Smoking is associated with lung cancer in humans (multivariable Spatial Error Model across U.S. counties) (Estimate = 2.04, p < 0.001).

    “spatial regression revealed this ecological pattern was primarily driven by geographic disparities in smoking prevalence (Estimate = 2.04, p < 0.001)”

    Humansmultivariable Spatial Error Model across U.S. countiesn = 2,701

    The impact of smoking prevalence on the spatial relationship between lung cancer screening access and mortality across U.S. counties

    Research SquarePreprint

  8. Smoking is linked with a higher risk of lung cancer in humans (TBI-exposed >=10-year smokers vs no TBI never smokers) (asHR 3.9, 95% CI 3.0-8.9).

    “the risk was increased among TBI-exposed ≥10-year smokers (adjusted subdistribution hazard ratio [asHR], 3.9; 95% CI, 3.0-8.9)”

    HumansTBI-exposed >=10-year smokers vs no TBI never smokers>=10 yearsn = 3,767

    Total body irradiation and smoking interact to increase lung cancer risk after blood or marrow transplantation

    Blood advances

  9. Smoking is linked with a higher risk of lung cancer in humans (P<0.001).

    “Independent predictors included age ≥55 years [adjusted odds ratio (OR) 4.82, 95% confidence interval (CI): 1.68-13.86], smoking history (P<0.001)”

    Humans

    Outcomes of lung cancer screening by low-dose computed tomography in the health screening program

    Journal of thoracic disease

  10. Smoking is linked with a higher risk of lung cancer in humans (HR 5.94, 95% CI 2.06–17.09).

    “smoking was associated with lung cancer (current vs. never: hazard ratio [HR], 5.94; 95% confidence interval [CI], 2.06–17.09)”

    Humans

    Lifestyle behaviors and site-specific cancer risk after kidney transplantation: age- and comorbidity-related differences in a nationwide cohort

    Research SquarePreprint

All 16

More on Smoking

Fine particulate matter

upin humans8upin silico2downin humans1downin silico1HR 0.972–1.82

11 studies
  1. Fine particulate matter is associated with lung cancer in humans (life-course exposure) (HR 1.193, 95% CI 1.064–1.337 per IQR increase).

    “asthma (HR: 1.171, 95% CI 1.105–1.241), LRTI (HR: 1.046, 95% CI 1.002–1.091), and lung cancer (HR: 1.193, 95% CI 1.064–1.337).”

    Humanslife-course exposureper interquartile range increase13–14 years of follow-upn = 47,737

    Life-Course Exposure to PM2.5 Constituents and Major Respiratory Diseases: Constituent-Specific Associations and Candidate Immune-Metabolic Signatures in a Large Prospective Cohort

    Lung

  2. Fine particulate matter is linked with a higher risk of lung cancer in humans (post smoking elimination).

    “mean PM2.5 concentrations and radon were important contributors to high lung cancer rates after accounting for smoking”

    Humanspost smoking eliminationlung

    Air pollution and lung cancer: an investigation of county-level residual incidence rates with smoking eliminated

    Environmental health : a global access science source

  3. Fine particulate matter is linked with a higher risk of lung cancer in individuals with non-cancerous lung disease (HR 1.049, 95% CI 1.027-1.073).

    “4.9 % higher risk of non-cancerous lung disease-to-lung cancer progression (HR=1.049, 95 % CI: 1.027-1.073)”

    Humansin individuals with non-cancerous lung diseaseeach 10 μg/m3 rise in 3-year fine particulate matter (PM2.5) concentration7-year

    Long-term particulate matter exposure and accelerated respiratory malignant transformation: A multi-state trajectory from initial injury to lung cancer

    Journal of hazardous materials

  4. Fine particulate matter is linked with a higher risk of lung cancer in humans (independent association) (HR 1.82, 95% CI 1.29-2.57).

    “Independently, high PM2.5 (HR 1.82, 95% CI 1.29-2.57) and high sedentary time (HR 2.10, 95% CI 1.55-2.84) increased risk.”

    Humansindependent associationn = 10,532

    Joint exposure to PM2.5, warm-season heat, and sedentary behavior accelerates incident lung cancer in ageing Chinese adults: evidence from CHARLS

    Frontiers in public health

  5. Fine particulate matter is linked with a lower risk of lung cancer in humans (HR 0.972 (95% CI, 0.948 to 0.996)).

    “and LC, 0.972 (95% CI, 0.948 to 0.996).”

    Humans10 μg/m312-month

    Mortality burden attributable to long-term exposure to fine particulate matter among older adults in Korea

    Epidemiology and health

  6. Fine particulate matter is associated with lung cancer in humans.

    “In this study, we found an association between PM2.5 exposure and lung cancer incidence.”

    Humans2012 to 2021

    Lung cancer risk and its potential association with PM2.5 in Bagmati province, Nepal-A spatiotemporal study from 2012 to 2021

    Frontiers in public health

  7. Fine particulate matter is linked with a higher risk of lung cancer in humans (multi-pollutant model, per 1-μg/m3 increase) (HR 1.008 (95% CI: 1.005, 1.011) per 1-μg/m3 increase).

    “Specifically, the HR was 1.008 (95% confidence interval [CI]: 1.005, 1.011) per 1-μg/m3 increase in PM2.5”

    Humansmulti-pollutant model, per 1-μg/m3 increase

    Long-term association of air pollution and incidence of lung cancer among older Americans: A national study in the Medicare cohort

    Environment international

  8. Fine particulate matter is associated with lung cancer in humans.

    “Lung cancer was associated with PM2.5 and BC in the adjusted single-pollutant models.”

    Humansmalesn = 11,679

    Exposure to low-level ambient air pollution and the relationship with lung and bladder cancer in older men, in Perth, Western Australia

    British journal of cancer

  9. Fine particulate matter is associated with lung cancer in humans (lifetime nonsmokers).

    “increasingly seen as an important modifiable exposure associated with lung cancer in nonsmokers.”

    Reviewlifetime nonsmokerslung

    Environmental PM2.5 exposure associated with lung cancer in nonsmokers: a narrative review of high-risk groups, mechanisms, and implications for screening

    Journal of toxicology and environmental health. Part B, Critical reviews

  10. Fine particulate matter raises the risk of lung cancer in silico (long-term exposure (28.4 μg/m3 vs baseline) in Errachidia) (RR = 1.30, 95% CI, 1.17-1.42).

    “28.4 μg/m3 in southern Errachidia (RR = 1.30, 95% CI, 1.17-1.42; AP = 23.29%).”

    In silicolong-term exposure (28.4 μg/m3 vs baseline) in Errachidia

    Spatial analysis of the burden of lung cancer attributable to long-term PM2.5 exposure in Morocco: a national assessment using the WHO AirQ+ model

    Environmental monitoring and assessment

All 12

More on Fine particulate matter

Telomere length

upin humans11OR 1.42–2.19

11 studies
  1. Telomere length is linked with a higher risk of lung cancer in humans (OR 1.6009, 95% CI 1.3056-1.9629).

    “The findings indicated significant positive associations between LTL and the risk of developing lung cancer [odds ratio (OR) = 1.6009, 95% confidence interval (CI) 1.3056-1.9629, P = 6.08 × 10−6]”

    Humans

    Causal effect between telomere length and thirteen types of cancer in Asian population: a bidirectional Mendelian randomization study

    Aging clinical and experimental research

  2. Telomere length is linked with a higher risk of lung cancer in humans (per 1-SD increase due to germline genetic variants) (OR 2.19, 95% CI 1.60-3.08).

    “followed by lung cancer [OR, 2.19 (95% CI, 1.60-3.08) and 1.45 (1.12-1.87)]”

    Humansper 1-SD increase due to germline genetic variants

    The Causal Relationship between Telomere Length and Cancer Risk: A Two-Sample Mendelian Randomization

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  3. Lung cancer is associated with telomere length in humans (COPD smokers 3 years prior to lung cancer diagnosis) (p < 0.001).

    “showed greater telomere length (p < 0.001) and increased serum 8-OHdG levels (p = 0.004) three years prior to LC diagnosis compared to the controls”

    HumansCOPD smokers 3 years prior to lung cancer diagnosis

    Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers

    Antioxidants (Basel, Switzerland)

  4. Telomere length is linked with a higher risk of lung cancer in humans (overall and particularly in never smokers) (p-trendcontinuous=2.6×10−5).

    “we found dose-response relationships between longer phenotypic LTL (p-trendcontinuous=2.6×10−5), longer gTL predicted using a polygenic score with 130 genetic instruments (p-trendcontinuous=4.2×10−10), and overall lung cancer risk”

    Humansoverall and particularly in never smokers

    Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank

    Thorax

  5. Telomere length is linked with a higher risk of lung cancer in never-smoking women (P trendLTL = 4×10-6; P trendgTL = 3×10-4).

    “striking dose-response relationships between longer LTL and gTL, and increased lung cancer risk among never-smoking women”

    Humansin never-smoking womenfemales

    Associations between Longer Leukocyte Telomere Length and Increased Lung Cancer Risk among Never Smokers in Urban China

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

  6. Telomere length is linked with a higher risk of lung cancer in humans (multivariate Cox model) (HR 1.09 [95% CI 1.03-1.16]).

    “An increase in LTL per interquartile range (IQR) was associated with a 9% increase in the risk for lung cancer (hazard ratio [HR] 1.09 [95% confidence interval (CI) 1.03-1.16]).”

    Humansmultivariate Cox modeln = 425,146

    Association of telomere length with risk of lung cancer: A large prospective cohort study from the UK Biobank

    Lung cancer (Amsterdam, Netherlands)

  7. Telomere length is linked with a higher risk of lung cancer in humans (Asian population) (OR 1.60, 95% CI 1.31 - 1.97).

    “longer telomere length significantly increased the risk of lung cancer in the Asian population”

    HumansAsian populationn = 212,453

    Association Between Telomere Length and Risk of Lung Cancer in an Asian Population: A Mendelian Randomization Study

    World journal of oncology

  8. Telomere length is linked with a higher risk of lung cancer in humans (regardless of smoking status).

    “longer LTL conferred an increased risk of lung cancer regardless of smoking status in the MR analyses”

    Humansregardless of smoking status

    Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome

    eLife

  9. Telomere length is linked with a higher risk of lung cancer in humans (OR=1.62, 95%CI=1.44-1.83, p=9.9×10 −15).

    “Longer LTL conferred an increased risk of lung cancer (OR=1.62, 95%CI=1.44-1.83, p=9.9×10 −15 )”

    Humans

    Common genetic variations in telomere length genes and lung cancer

    medRxivPreprint

  10. Telomere length raises the risk of lung cancer in humans (nine prospective studies) (OR 1.42, 95% CI 1.24-1.63, +42%).

    “longer LTL was associated with a significant 42% increment in all types of lung cancer risk (OR 1.42, 95% CI 1.24-1.63).”

    Reviewnine prospective studies

    Leucocyte Telomere Length and Lung Cancer Risk: A Systematic Review and Meta-Analysis of Prospective Studies

    Cancers

All 11

More on Telomere length

Smoking cessation

downin humans7downin silico1−32% reductionHR 0.76–0.87

8 studies
  1. Smoking cessation is linked with a lower risk of lung cancer in humans among FOXO3-G carriers; per additional year of smoking cessation (HR 0.87; 95% CI 0.81-0.94).

    “each additional year of smoking cessation was associated with a reduced risk of LC (HR, 0.87; 95% CI, 0.81-0.94)”

    Humansamong FOXO3-G carriers; per additional year of smoking cessationmales

    Gene variant linked to lower lung cancer risk in former smokers

    Translational lung cancer research

  2. Smoking cessation is linked with a lower risk of lung cancer in humans (HR 0.760, p<0.001).

    “Lung cancer risk significantly decreased after two years of smoking cessation (2-3 years after cessation: hazard ratio 0.760, p<0.001)”

    Humans2-3 years

    Effect of Smoking Cessation Duration on Lung Cancer Incidence: A Nationwide Retrospective Cohort Study in Korea

    Cancer research and treatment

  3. Smoking cessation is associated with lung cancer in humans (Patients with COPD; smoking cessation compared with continued smoking) (aHR 0.85, 95% CI 0.72–0.99).

    “quitters had significantly lower risks of lung cancer (adjusted HR [aHR], 0.85; 95% CI, 0.72–0.99)”

    HumansPatients with COPD; smoking cessation compared with continued smokingn = 23,262

    E-cigarette switching in COPD: reduced cardiovascular events without improvement in respiratory outcomes

    Respiratory research

  4. Smoking cessation is linked with a lower risk of lung cancer in humans (carrying C > A/G > T mutation) (39.5% decrease).

    “Men ≥ 65 carrying C > A/G > T mutation had the highest lung cancer incidence decrease of 39.5% after five years quitting in stratified elderly groups”

    Humanscarrying C > A/G > T mutationfive yearsmales

    Ensemble machine learning models for lung cancer incidence risk prediction in the elderly: a retrospective longitudinal study

    BMC cancer

  5. Smoking cessation lowers the risk of lung cancer in humans (smoking cessation).

    “smoking cessation improve survival rates and decrease lung cancer incidence rates”

    Reviewsmoking cessation

    Lung cancer screening by low-dose computed tomography: A modelling study to evaluate radiation-induced cancer risks, and the influence of smoking behavior

    Cancer epidemiology

  6. Smoking cessation lowers the risk of lung cancer in humans.

    “Quitting smoking at older ages reduces lung cancer risk and increases life expectancy.”

    Review

    Reducing Lung Cancer Mortality by Providing Smoking Cessation Support in the Lung Cancer Screening Setting: Missed Opportunities and Lessons Learned on Both Sides of the Atlantic

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

  7. Smoking cessation lowers the risk of lung cancer in silico (31.81% reduction).

    “In elderly men and women, the maximal reductions of lung cancer incidence were 31.81% and 24.62% separately.”

    In silicomales

    Deep Q-networks with web-based survey data for simulating lung cancer intervention prediction and assessment in the elderly: a quantitative study

    BMC medical informatics and decision making

  8. Smoking cessation lowers the risk of lung cancer in humans after long-term smoking.

    “the decreased relative risk after smoking cessation suggests a similarity between the effects of smoking and aging”

    Reviewafter long-term smoking

    Smoking: additional burden on aging and death

    Genes and environment : the official journal of the Japanese Environmental Mutagen Society

More on Smoking cessation

GrimAge

upin humans5OR 1.79

5 studies
  1. GrimAge is linked with a higher risk of lung cancer in humans.

    “The strongest associations were for lung cancer with GrimAge and its derivatives.”

    Humans

    Epigenetic markers of ageing and cancer risk

    Ageing research reviews

  2. GrimAge predicts lung cancer in humans (AUC 0.72, 95% CI 0.67–0.77).

    “compared with 0.72 (95% CI = 0.67-0.77) for the PCGrimAge model (Pdifference = 0.03).”

    Humansblood

    DNA methylation-based clocks, tobacco smoking, and lung cancer risk

    BMC medicine

  3. GrimAge is linked with a higher risk of lung cancer in humans after adjustment for age and tobacco smoking (OR 1.79, 95% CI 1.56–2.06).

    “PCGrimAge (a principal component-denoised GrimAge): OR = 1.79, 95% CI = 1.56-2.06), after adjustment for age and tobacco smoking.”

    Humansafter adjustment for age and tobacco smokingblood

    DNA methylation-based clocks, tobacco smoking, and lung cancer risk

    BMC medicine

  4. GrimAge is associated with lung cancer in humans (p = 0.047).

    “GrimAge acceleration was significantly correlated with LC risk (p = 0.047)”

    Humans

    The role of senescence indicators in the linkage between high-glycemic food intake and lung cancer: a Mendelian randomization study

    Journal of clinical biochemistry and nutrition

  5. GrimAge is linked with a higher risk of lung cancer in humans.

    “All three algorithms showed strong positive associations with lung cancer risk in a dose response manner, with adjusted HRs per SD increase in AgeAccelPheno, AgeAccelGrim, and MRscore-8CpGs, of 1·37 (1·03-1·82), 1·74 (1·11-2·73)”

    Humanswhole blood17 years

    Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study

    EBioMedicine

  6. GrimAge is linked with a higher risk of lung cancer in humans (RR per SD 1.82 (95% CI 1.44 to 2.30)).

    “the association with lung cancer risk was much larger (RR per SD = 1.82, 95% confidence interval [CI] = 1.44 to 2.30)”

    Humansafter adjustment for smoking status, pack-years, starting age, time since quitting and other cancer risk factorsblood

    Biological Aging Measures Based on Blood DNA Methylation and Risk of Cancer: A Prospective Study

    JNCI cancer spectrum

More on GrimAge

Chronic obstructive pulmonary disease

upin humans4HR 9.91

4 studies
  1. Chronic obstructive pulmonary disease is associated with lung cancer in humans (HR 9.91, 95% CI 9.18–19.7; p-adj. < 0.0001).

    “chronic obstructive pulmonary disease and subsequent lung cancer diagnosis risk (female hazard ratio [HR] = 9.91, 95% confidence interval [CI]: 9.18-19.7, p-adj. < 0.0001;”

    Humansfemales

    Cancer incidence following non-neoplastic medical conditions: a prospective population-based cohort study

    Acta oncologica (Stockholm, Sweden)

  2. Chronic obstructive pulmonary disease raises the risk of lung cancer in humans.

    “Chronic obstructive pulmonary disease (COPD) substantially increases the risk of lung cancer”

    Review

    Respiratory omics for early detection of COPD-to-lung cancer transition: mechanisms, biomarkers and clinical translation

    Frontiers in cell and developmental biology

  3. Chronic obstructive pulmonary disease raises the risk of lung cancer in humans.

    “Chronic obstructive pulmonary disease (COPD) represents an independent risk factor for lung cancer development.”

    Review

    RNA-Binding Proteins as a Molecular Link between COPD and Lung Cancer

    COPD

  4. Chronic obstructive pulmonary disease raises the risk of lung cancer in lung transplant candidates, mainly previous smokers.

    “Lung transplant candidates at higher risk for developing lung cancer [mainly previous smokers with chronic obstructive lung disease (COPD) and idiopathic pulmonary fibrosis (IPF) or older patients]”

    Reviewin lung transplant candidates, mainly previous smokers

    Lung cancer: a rare indication for, but frequent complication after lung transplantation

    Journal of thoracic disease

More on Chronic obstructive pulmonary disease

Low-dose computed tomography screening

upin humans3downin humans1+27% screened

4 studies
  1. Low-dose computed tomography screening is associated with lung cancer in humans (15 cases, PPV 24%).

    “Fifteen cases of Lung cancer were found, yielding a positive prediction value (PPV) of 24%.”

    Human trialfemalesn = 990

    The Stockholm Pilot study for Lung cancer Screening (Stockholm PLUS): feasibility of baseline low-dose CT lung cancer screening in a high-risk Swedish female population

    Acta oncologica (Stockholm, Sweden)

  2. Low-dose computed tomography screening is associated with lung cancer in eligible persons with HIV (27% screened).

    “Overall, 13% of PWH were eligible for screening, among whom less than one-third (27%) received screening at least once during follow-up.”

    Humansin eligible persons with HIVlung2018-2023n = 2,798

    Lung cancer screening among people with HIV, 2018-2023

    International journal of STD & AIDS

  3. Low-dose computed tomography screening is associated with lung cancer in humans (post-2014 guideline era in adults aged 55-79 years) (annual AAMR decreased by 3.03% in CDC WONDER and 2.58% in GBD).

    “Annual AAMR decreased by 3.03% in CDC WONDER and 2.58% in GBD; AAIR declined by 1.85% and 2.37%, respectively.”

    Humanspost-2014 guideline era in adults aged 55-79 years

    Population-Level Trends in Lung Cancer Mortality and Stage Distribution During the USPSTF LDCT Guideline Era: A Multi-Database Quasi-Experimental Study

    Cancer control : journal of the Moffitt Cancer Center

  4. Low-dose computed tomography screening is associated with lung cancer in humans (2.2%, 95% CI: 1.5-3.1%).

    “lung cancer was diagnosed in 31 patients (2.2%, 95% CI: 1.5-3.1%).”

    Humanslungsingle roundmalesn = 1,409

    Single-Round LDCT Screening in Men Aged ≥ 70 Years: Prevalence of Pulmonary Nodules and Lung Cancer Detection

    Cancers

More on Low-dose computed tomography screening

Sybil

upin humans3

3 studies
  1. Sybil predicts lung cancer in humans (Tertiary safety-net hospital lung cancer screening cohort) (Overall AUC 0.819–0.912; 2-year AUC 0.746 in Lung-RADS 1 and 2 cases).

    “Sybil's overall area under the curve (AUC) ranged from 0.819 to 0.912; while its 2-year AUC for Lung-RADS 1 and 2 cases was 0.746.”

    HumansTertiary safety-net hospital lung cancer screening cohortlungn = 3,120

    Investigating AI's potential in risk-stratifying lung cancer screenings for extending screening intervals and reducing workload: A retrospective analysis of a tertiary hospital cohort

    medRxivPreprint

  2. Sybil predicts lung cancer in humans (Framingham Heart Study) (CAC AUC 0.88 (95% CI 0.81–0.95) versus full-lung AUC 0.92 (95% CI 0.87–0.97)).

    “the AUC for 1-year LC prediction was 0.88 (95% CI: 0.81-0.95) on CAC scans versus 0.92 (95% CI: 0.87-0.97) on full lung scans.”

    HumansFramingham Heart StudyCAC scanslung1-year predictionn = 2,415

    Performance of Sybil AI for lung cancer risk assessment: a head-to-head comparison of cardiac vs. lung CT scans

    ESC Congress 2026 abstract

  3. Sybil predicts lung cancer in humans (AUC 0.91 (95% CI, 87.7-94.6)).

    “AUCs ranging from 0.91 at 1 year (95% CI, 87.7-94.6) to 0.82 at 6 years”

    Humans1 year

    Brief Report: Validation of the Sybil Lung Cancer Risk Prediction Model in a Predominantly Black Screening Cohort

    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

More on Sybil

Neutrophil-to-lymphocyte ratio

upin humans3

3 studies
  1. Neutrophil-to-lymphocyte ratio is associated with lung cancer in humans Across all three adjusted models.

    “Increased PAR, CAR, CLR, and NLR were significantly associated with higher lung cancer risk across all three adjusted models.”

    HumansAcross all three adjusted modelsn = 416,656

    Composite inflammatory indices and incident lung cancer risk in an exploratory statistical mediation analysis

    Scientific reports

  2. Neutrophil-to-lymphocyte ratio is linked with a higher risk of lung cancer in current smokers with high inflammatory marker levels (AHR=3.78; 95% CI: 2.65-5.39).

    “NLR: AHR=3.78; 95% CI: 2.65-5.39”

    Humansin current smokers with high inflammatory marker levelsmales

    Systemic inflammatory indices and lung cancer risk by smoking and alcohol use in Korean men: A secondary dataset analysis of the Korean Cancer Prevention Study-II

    Tobacco induced diseases

  3. Neutrophil-to-lymphocyte ratio is associated with lung cancer in humans.

    “Sex-stratified analyses revealed stronger associations between Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune Inflammatory Index (SII) and lung cancer in men”

    Humans6.6 yearsmales

    Towards Personalised Screening for Lung Cancer: A Sex-Stratified Approach in a Danish Cohort Integrating Pre-Diagnostic Systemic Inflammatory Indexes with Smoking Status and Age

    Respiration; international review of thoracic diseases

More on Neutrophil-to-lymphocyte ratio

Tuberculosis

upin humans3OR 1.76

3 studies
  1. Tuberculosis is linked with a higher risk of lung cancer in humans.

    “lung cancer was independently associated with low education, wealth, solid-fuel use, occupational exposure, insufficient physical activity, meat-based and processed food dietary patterns, secondhand smoke (SHS), prior tuberculosis, and family history of cancer.”

    Humans

    Lung Cancer Risk Factors Beyond Smoking in Ethiopia: A Multicenter Matched Case-Control Study

    Cancers

  2. Tuberculosis raises the risk of lung cancer in humans (history of pulmonary tuberculosis) (pooled effect estimate: 2.39, 95% CI: 1.91–2.99).

    “Pulmonary TB was significantly associated with increased lung cancer risk (pooled effect estimate: 2.39, 95% CI: 1.91–2.99, p < 0.0001).”

    Reviewhistory of pulmonary tuberculosislung

    Association Between Pulmonary Tuberculosis and Lung Cancer Risk: A Meta-Analysis

    Research SquarePreprint

  3. Tuberculosis is associated with lung cancer in humans (Never-smokers; case-control studies) (OR 1.76, 95% CI 1.47–2.11).

    “TB (16 studies) and CB (9 studies) were associated significantly with increased lung cancer risk”

    ReviewNever-smokers; case-control studies

    Associations Between Prior Lung Diseases and Risk of Lung Cancer in Populations With No Smoking History: A Systematic Review and Meta-Analysis

    Chest

More on Tuberculosis

Beta-carotene

upin humans3OR 1.82

3 studies
  1. Beta-carotene raises the risk of lung cancer in humans (10-year follow-up) (OR 1.82 (95% CI, 1.06-3.12)).

    “the odds ratio (OR) of having lung cancer was 1.82 (95% CI, 1.06-3.12; P = .02) for those randomly assigned to beta carotene”

    Human trial10-year follow-up10 yearsn = 3,882

    Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28

    JAMA ophthalmology

  2. Beta-carotene raises the risk of lung cancer in humans (intermediate AMD in smokers).

    “elimination of β-carotene, which increases the risk of lung cancer in smokers.”

    Reviewintermediate AMD in smokers

    A Datasheet for Age-Related Eye Disease Study 2 on the Database of Genotypes and Phenotypes

    Ophthalmology science

  3. Beta-carotene raises the risk of lung cancer in humans among smokers.

    “several other studies also provide disturbing evidence of risk, such as increased lung cancer risk with beta-carotene use among smokers”

    Reviewamong smokers

    NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention

    NIH consensus and state-of-the-science statements

More on Beta-carotene

Low-dose computed tomography

upin humans2+5.5%

2 studies
  1. Low-dose computed tomography predicts lung cancer in humans (stratified by baseline LDCT results into LDCT + vs LDCT -) (21.8 % vs 3.0 %).

    “with significantly higher incidence in the LDCT + group (21.8 % vs 3.0 %, p < 0.0001)”

    Human trialstratified by baseline LDCT results into LDCT + vs LDCT -median follow-up of 9.4 yearsn = 4,119

    Long-term efficacy and adherence of a lung cancer screening strategy with extended LDCT intervals: Results from the BioMILD trial

    Lung cancer (Amsterdam, Netherlands)

  2. Low-dose computed tomography is associated with lung cancer in humans (5.5%).

    “The detection rate of positive nodules and of lung cancer was 78.4% and 5.5%, respectively.”

    Humans10-year follow-up

    Analysis of pulmonary nodules detected by annual low-dose computed tomography in the elderly during a 10-year follow-up

    Geriatrics & gerontology international

More on Low-dose computed tomography

Italung biomarker panel

upin humans1

1 study
  1. Italung biomarker panel predicts lung cancer in humans (close to the time of diagnosis) (95% SE (20/21)).

    “out of 21 LC cases, 20 were positive in the ITALUNG biomarker panel [95% SE; 95% C.I. 0.86-1.04]”

    Human trialclose to the time of diagnosisn = 21

    Biomarker Detection of Lung Cancers Before Clinical Symptoms or the Use of Traditional Imaging Methods in the ITALUNG Trial

    International journal of molecular sciences

More on Italung biomarker panel

Multiplex sev device

upin humans1

1 study
  1. Multiplex sev device predicts lung cancer in humans (prospective cohort distinguishing benign lung changes from early-stage lung cancer).

    “we accurately differentiate between benign lung changes and early-stage lung cancer.”

    Human trialprospective cohort distinguishing benign lung changes from early-stage lung cancern = 68

    Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature

    Cell reports. Medicine

More on Multiplex sev device

All 341

Trial sponsors

Funding

333 grants since 2016

National Cancer Institute$273MUS Department of Veterans AffairsOffice of the President, University of California$12.6M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human observational studies associate epigenetic age acceleration, clonal hematopoiesis and longer telomeres with higher lung cancer risk, with some epigenetic associations persisting after adjustment for smoking. A human trial reports lower lung cancer risk with Centrum Silver multivitamins.

  2. Summary rewritten as its findings changed.

    As it read before

    Human studies associate higher lung cancer risk with clonal hematopoiesis, faster blood epigenetic aging and metabolic syndrome; preprints also link imaging-derived age acceleration to risk. Higher dietary quality and healthy lifestyles associate with lower risk, whereas air pollution associates with higher risk. Total bilirubin-to-albumin ratio associates with lower risk in males but higher risk in females.

  3. Summary rewritten as its findings changed.

    As it read before

    Human studies associate smoking, metabolic syndrome and higher polygenic risk scores with greater lung cancer risk, and Mediterranean diet and healthy lifestyle with lower risk. Screening is associated with increased early-stage but decreased late-stage incidence in humans. Human trials assess low-dose computed tomography and the ITALUNG biomarker panel for prediction; reviews link air pollution to increased risk.

  4. Summary rewritten as its findings changed.

    As it read before

    Human cohort studies link particulate ions, microplastics, ASXL1 mutations, smoking, and medical debt to increased lung cancer risk, while sleep and dietary polyunsaturated fatty acids are associated with reduced risk. Reviews also link air pollution, tuberculosis, and Y-chromosome loss.

  5. Summary written from the findings.

Latest

Dec 2025: 45Jan 2026: 130Feb 2026: 123Mar 2026: 116Apr 2026: 28May 2026: 36Jun 2026: 44Jul 2026: 53Aug 2026: 105Sep 2026: 109Oct 2026: 132Nov 2026: 72993 papers in 12 months
ERJ Open Research

Four blood fats linked to lung disease and lung cancer deaths

Twofold higher levels of four blood fats were linked to 50% to over 400% higher relative risks of chronic respiratory and lung cancer death.Twofold higher levels of four blood fats were linked to 50% to over 400% higher relative risks of chronic respiratory and lung cancer death.

Cohort · 4,612 peopleLung cancer
Genes

Mobile DNA insertions may not be confined to lung tumors

Genome sequencing in 55 people with lung cancer found comparable levels of candidate mobile DNA insertions in tumors and nearby normal-looking lung tissue.Genome sequencing in 55 people with lung cancer found comparable levels of candidate mobile DNA insertions in tumors and nearby normal-looking lung tissue.

Cross-sectional · 55 peopleLung
Medicine and Science in Sports and Exercise

Higher midlife fitness linked to longer survival after cancer in men

High-fitness men with colorectal, lung or prostate cancer had a 33–41% lower relative risk of death from any cause than low-fitness men.High-fitness men with colorectal, lung or prostate cancer had a 33–41% lower relative risk of death from any cause than low-fitness men.

Cohort · 28,612 peopleCancer
Cancer Prevention Research

Low predicted muscle mass showed no strong link to cancer risk

Men with low predicted muscle mass had a hazard ratio of 1.04 for overall cancer versus other men—a small difference in relative risk.Men with low predicted muscle mass had a hazard ratio of 1.04 for overall cancer versus other men—a small difference in relative risk.

Cohort · 4,441,403 peopleCancer

See all 1,995 papers on lung cancer